Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary Shares
Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021     157,237,435          
Beginning balance at Dec. 31, 2021 $ 1,081,618 $ (1,545) $ 157,237 $ 0 $ 1,670,033 $ (7,135) $ (738,517) $ (1,545)
Beginning balance (in shares) at Dec. 31, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 4,963       4,963      
Ordinary shares issued related to founders advisory fees - related party (in shares)     5,952,992          
Ordinary shares issued related to founders advisory fees - related party 13,783   $ 5,954   7,829      
Ordinary shares issued related to warrants exercised (in shares)     44,115          
Ordinary shares issued related to warrants exercised 529   $ 44   485      
Net income 36,963           36,963  
Other comprehensive income (loss) 126         126    
Ending balance (in shares) at Mar. 31, 2022     163,234,542          
Ending balance at Mar. 31, 2022 $ 1,136,437   $ 163,235 $ 0 1,683,310 (7,009) (703,099)  
Ending balance (in shares) at Mar. 31, 2022       0        
Beginning balance (in shares) at Dec. 31, 2022 156,797,806   163,234,542          
Beginning balance at Dec. 31, 2022 $ 1,138,900   $ 163,235 $ (49,341) 1,698,781 (25,471) (648,304)  
Beginning balance (in shares) at Dec. 31, 2022 6,436,736     6,436,736        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation $ (3,074)       (3,074)      
Ordinary shares issued related to founders advisory fees - related party (in shares)     1,831,653          
Ordinary shares issued related to founders advisory fees - related party 0   $ 1,832   (1,832)      
Ordinary shares repurchased (in shares)       115,570        
Ordinary shares repurchased (864)     $ (864)        
Net income 9,431           9,431  
Other comprehensive income (loss) $ 1,593         1,593    
Ending balance (in shares) at Mar. 31, 2023 158,513,889   165,066,195          
Ending balance at Mar. 31, 2023 $ 1,145,986   $ 165,067 $ (50,205) $ 1,693,875 $ (23,878) $ (638,873)  
Ending balance (in shares) at Mar. 31, 2023 6,552,306     6,552,306